Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access


Long acting risperidone in treatment of schizophrenia: A retrospective study

Mehmet Yumru, Haluk A. Savaş, M. Hanifi Kokaçya, Osman Vırıt.

Objective: In this study it is aimed to investigate the efficacy of longacting
risperidone in treatment of schizophrenia.

Method: The files of patients whom diagnosed schizophrenia
according to DSM IV and had been treated with long acting
risperidone in Gaziantep University Medical of Faculty Department of
Psychiatry, Pscyhotic Disorders Unit, was investigated retrospectively.

Results: End of the study clinical improvement was achieved by 66.7%
(20/30). In the course of 6 months follow up period, weight gain in 2
patients (6.6%), late dyskinesia in 1 patient (3.3%), oculogyric crisis
(3.3%), and akathisia in 1 patient (3.3%) was observed.

Conclusion: This is the first study in our country which evaluates the efficacy
of long-acting risperidone treatment for 24 weeks period and long-acting
risperidone was appeared lead to clinical improvement in proportion
%66.7 especially for schizophrenia patients with partial compliance.

Key words: Long-acting risperidone, efficacy, schizophrenia

Share this Article

Journal of Apitherapy


ScopeMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons